Almirall, S.A. (LBTSF)
OTC
Closed
Oct 7, 2026
Day's Range
15.3552 wk Range
13.36Overview - LBTSF - Almirall, S.A.
Key Statistics
Valuation
Enterprise Value
3.77B
P/E (Trailing)
‪61.40‬
Price / Sales (TTM)
‪2.88‬
Price / Book
‪1.94‬
EV / EBITDA
‪15.20‬
Profitability
Gross Margin
‪185.11%‬
Profit Margin
‪5.11%‬
Operating Margin
‪13.33%‬
Return on Assets
‪2.69%‬
Return on Equity
‪3.95%‬
Ownership
Shares Outstanding
217.60M
Float
78.27M
Held by Insiders
‪64.07%‬
Held by Institutions
‪16.81%‬
Price stats
Beta
‪0.14‬
50-Day Avg
‪15.35‬
200-Day Avg
‪15.37‬
Dividends
Payout Ratio
‪66.79%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LBTSF - Almirall, S.A.
Peers - LBTSF - Almirall, S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- LBTSFOTCAlmirall, S.A.3.34BMarket Cap+12.96%52-week change61.40P/E (Trailing)‪5.11%‬Profit Margin
- MKGAFOTCMerck KGaA67.92BMarket Cap+9.27%52-week change25.32P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR67.10BMarket Cap+8.97%52-week change24.90P/E (Trailing)‪11.21%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR45.20BMarket Cap+7.87%52-week change53.10P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG44.15BMarket Cap+11.81%52-week change51.88P/E (Trailing)‪14.57%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.43.14BMarket Cap-30.46%52-week change37.14P/E (Trailing)‪86.20%‬Profit Margin
- HLNCFOTCHaleon plc38.69BMarket Cap+1.79%52-week change18.58P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - LBTSF - Almirall, S.A.
About
Almirall, S.A. is a Spanish pharmaceutical company specializing in medical dermatology, headquartered in Barcelona and founded in 1944. It focuses on researching, developing, manufacturing, and marketing innovative medicines to address unmet needs in skin health, particularly for conditions like psoriasis, atopic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
